Search results
HLS Therapeutics Inc. (TSE:HLS): When Will It Breakeven?
Simply Wall St. via Yahoo Finance· 2 years agoHLS Therapeutics Inc. (TSE:HLS) is possibly approaching a major achievement in its business, so we...
Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk
Zacks via Yahoo Finance· 1 month agoEsperion Therapeutics, Inc. ESPR and partner Daiichi Sankyo Europe GmbH announced that the European...
Esperion Therapeutics (ESPR) Down 24% in a Week: Here's Why
Zacks via Yahoo Finance· 1 year agoShares of Esperion Therapeutics (ESPR) fell last week as the company's cardiovascular outcome CLEAR...
5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates
Zacks via Yahoo Finance· 4 months agoIt has been a rather lukewarm earnings season for the drug and biotech sector. Majority of large...
Esperion (ESPR) to Expand Nilemdo and Nustendi Label in Europe
Zacks via Yahoo Finance· 12 months agoEsperion ESPR announced the submission of a type II(a) variation application for label expansion of...
Esperion (ESPR) Q4 Earnings Top, Stock Up on Strong Revenues
Zacks via Yahoo Finance· 4 months agoEsperion Therapeutics, Inc. ESPR incurred a loss per share of 50 cents in the fourth quarter of...
Esperion (ESPR) Settles Milestone Dispute With Daiichi Sankyo
Zacks via Yahoo Finance· 6 months agoDaiichi Sankyo amends its existing collaboration with Esperion (ESPR), including the resolution of a...
Weekly Upgrades and Downgrades
InvestorPlace via Yahoo Finance· 2 months agoDuring these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking...
Gilead Sciences Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 2 weeks agoGilead Sciences Inc (NASDAQ:GILD) recently announced a dividend of $0.77 per share, payable on 2024-06-27, with the ex-dividend date set for 2024-06-14....
FTC Sues Over Amgen’s $28 Billion Horizon Therapeutics Deal
Bloomberg via Yahoo News· 1 year ago(Bloomberg) -- The Federal Trade Commission sued to block Amgen Inc.’s $27.8 billion deal to buy...
